Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: benwood who wrote (96032)	5/23/2002 4:18:34 PM
From: ild	Read Replies (1) \| Respond to of 132070

VASO had a heart attack today. -NG- finance.yahoo.com Highest volume since 23-Feb-01 Lowest price since Dec 2000

To: benwood who wrote (96032)	5/24/2002 10:59:42 AM
From: ild	Read Replies (1) \| Respond to of 132070

Despite some of the limitations inherent in this analysis, these and other recent data suggest that perhaps we need to .re-examine our treatment algorithm for symptomatic coronary artery disease patients and opt for EECP first in select patient subsets rather than using EECP as a last resort strategy." Dr. Soran continued, "Based on our experience with EECP to date, I believe there are many angina patients who would consider having EECP if it meant that they could avoid or at least defer having a more invasive procedure performed. This is analogous to the current situation in which some patients who are eligible for both PCI and bypass surgery opting to have a less invasive catheter-based procedure first despite the fact that surgery may provide more effective long-term relief of symptoms." ragingbull.lycos.com